ALCOX:EPA
NicOx SA
€ 0.31
0.00%
(0.00) Siku 1
9 Okt, 17:35:31 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALCOX...
Mtaji wa soko
32.06M
Wastani wa kiasi cha mauzo
elfu 164.58
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 0.57
Chini kwa wiki 52
€ 0.28
EPS
-€ 0.03
Hisa za wawekezaji
97.55M
Idadi ya wafanyakazi
10
Mtaji wa soko
32.06M
Wastani wa kiasi cha mauzo
elfu 164.58
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
€ 0.57
Chini kwa wiki 52
€ 0.28
EPS
-€ 0.03
Hisa za wawekezaji
97.55M
Idadi ya wafanyakazi
10
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Kalkine Media
·
dakika 12 zilizopita
Are Streaming and Park Strength Driving Walt Disney's (NYSE:DIS) Rebound?
TradingView
·
dakika 19 zilizopita
SPX: S&P 500 Nears Record as Traders Gear Up for Earnings, Inflation Data
MarketBeat
·
dakika 21 zilizopita
Fermi Inc. (NASDAQ:FRMI) Stock Has Consensus Target Price of $20.67 According to Brokerages
Wasifu
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
Kuhusu NicOx SA
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi10
Lilianzishwa1996
Makao makuuValbonne, Provence-Alpes-Côte d'Azur, Ufaransa
Sekta-
Tovutinicox.com